Detalhe da pesquisa
1.
Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
Clin Exp Allergy
; 48(2): 196-204, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164723
2.
The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.
Allergy
; 70(11): 1393-405, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198455
3.
The Fcε receptor I pathway is crucial but not exclusive for basophil activation in patients with autoimmune forms of chronic spontaneous urticaria.
J Eur Acad Dermatol Venereol
; 34(12): e825-e827, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32491222
4.
IL-33 is a mediator rather than a trigger of the acute allergic response in humans.
Allergy
; 69(2): 216-22, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24205920
5.
In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
Clin Exp Allergy
; 43(9): 1027-37, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957338
6.
T cell responses to drugs and drug metabolites.
Exp Suppl
; 104: 137-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24214623